
A kiss may be just a kiss, but we're looking for unique materials to add to lip products for new lip sensations and
experiences (such as cooling, warming, numbing, tingling and flavors), solutions that can impart prolonged sensate
experiences, and solutions that can impart not-yet-known sensations.
Looking for a finished producer of Cephelexin syrups and Omeprazole 20mg x10 caps with EU dossier and current EU registartion in at least 2 EU countries for export.
The EU CTD dossier is in development.
Reference Product:
Name of the product: Fluimucil 600
Name of the company: Zambon Spa
Patent expiry date: N/A
Dossier:
Language: English
Format: EU CTD
Farmavita.Net member is seeking bacteria strains and fermentation technologies to produce the following products Lycopene, Chlortetracycline and Acetylisovaleryltylosin.
Over the past decade, open innovation has begun transforming the way global companies develop new products, as executives increasingly recognize the benefits of exposing internal R&D to outside ideas. Now, some organizations are going even further by applying open-source thinking to improve a range of core business processes. Aided by rapidly changing technology, these leaders are looking outside the gates to develop faster and better solutions to a variety of strategic, operational, and organizational problems.
Download free 9 pages report at our Download Section.

Calotropis procera R. Br. (Asclepidaceae) is a shrub which widely distribute in the world. The plant is used in the treatment of many disease and disorder both in humans and veterinary application. The present work was undertaken to investigate the anti-diarrhoeal activity of ethanolic extract of root (200 mg/kg BW) of Calotropis procera against castor oil induced diarrhoea in experimental animal and was found to be significant results.
The whole 6 pages article is available for download at Downloads section of Farmavita.Net.

21-23 June 2010, Le Méridien Beach Plaza, Monte-Carlo, Monaco
The PharmaBrand Europe Summit 2010 will bring together senior-level executives from Europe's largest organisations with a select and diversified group of leading edge Solution Providers. Do not miss this opportunity to network with your peers and form new alliances. Get a head start on your competition and start building relationships today.

Datamonitor forecasts that total sales for the seven major rheumatoid arthritis markets will grow from $7 billion in 2007 to over $12 billion in 2017. The sustained uptake of anti-TNFs combined with the launch of several new biologic products will drive growth in the short-and mid-term. However, biosimilar entry will cause a small contraction in market value at the end of the forecast period.
Complete your profileThe more information you put into your profile the easier it is for others to find you. Compare your profile with those of other members. The more you put into the network, the more benefit you will derive from community. |